| C09DA03 |
Valsartan, Hydrochlorothiazide |
Co-Valsacor |
Film coated tablet |
160 mg/25 mg |
mg |
28 |
KRKA, d.d., Словения |
1 |
tabl |
- |
11.12 |
0.23964 |
6.71 |
50% |
3.36 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
№ 43/07.01.2010; № 238/04.11.2011; НСР-1334/07.10.2013; НСР-3688/06.06.2014.; НСР-6934/12.08.2015; НСР-10805/03.11.2016 |
02.12.2016 |
08.09.2012 |
|
Активен |
2895 |
| C09DA03 |
Valsartan, Hydrochlorothiazide |
Co-Valsacor |
Film coated tablet |
160 mg/12,5 mg |
mg |
28 |
KRKA, d.d., Словения |
1 |
tabl |
- |
11.12 |
0.32767 |
9.17 |
50% |
4.58 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
№ 43/07.01.2010; № 238/04.11.2011; НСР-1333/07.10.2013; НСР-3688/06.06.2014; НСР-6934/12.08.2015; НСР-10806/03.11.2016 |
02.06.2017 |
08.09.2012 |
|
Активен |
2896 |
| C09DA03 |
Valsartan, Hydrochlorothiazide |
Co-Valsacor |
Film coated tablet |
80 mg/ 12,5 mg |
mg |
28 |
KRKA, d.d., Словения |
1 |
tabl |
- |
11.92 |
0.25607 |
7.17 |
50% |
3.58 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
№ 43/07.01.2010; НСР-2047/11.12.2013 |
02.01.2014 |
08.09.2012 |
|
Заличен |
815 |
| C09DA03 |
Valsartan, Hydrochlorothiazide |
Co-Valstor |
Film coated tablet |
160 mg/12,5 mg |
mg |
30 |
Чайкафарма Висококачествените лекарства АД, България |
1 |
tabl |
- |
21.8 |
0.32767 |
9.83 |
50% |
4.91 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
КЦРР-1708/27.11.2012 г. |
02.06.2017 |
|
|
Активен |
1107 |
| C09DA03 |
Valsartan, Hydrochlorothiazide |
Co-Valstor |
Film coated tablet |
160 mg/25 mg |
mg |
30 |
Чайкафарма Висококачествените лекарства АД, България |
1 |
tabl |
- |
21.8 |
0.23964 |
7.19 |
50% |
3.59 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
КЦРР-1497/15.10.2012 г.; НСР-12087/21.03.2017 |
02.05.2017 |
|
|
Заличен |
1108 |
| C09DA03 |
Valsartan, Hydrochlorothiazide |
Sarteg HCT |
Film coated tablet |
80 mg/ 12,5 mg |
mg |
28 |
EGIS Pharmaceuticals PLC, Унгария |
1 |
tabl |
- |
11.23 |
0.17839 |
4.99 |
50% |
2.49 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
№25/03.08.2009; НСР-2825/21.02.2014 и КП-5/15.01.2015; НСР-6274/22.05.2015 (допуска предварително изпълнение) |
02.06.2015 |
08.09.2012 |
|
Заличен |
3501 |
| C09DA03 |
Valsartan, Hydrochlorothiazide |
Sarteg HCT |
Film coated tablet |
160 mg/ 12.5 mg |
mg |
28 |
EGIS Pharmaceuticals PLC, Унгария |
1 |
tabl |
- |
10.82 |
0.27303 |
7.64 |
50% |
3.82 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
№25/03.08.2009; НСР-2823/21.02.2014 и КП-3/15.01.2015; НСР-6271/22.05.2015 (допуска предварително изпълнение) |
02.06.2015 |
08.09.2012 |
|
Заличен |
3499 |
| C09DA03 |
Valsartan, Hydrochlorothiazide |
Sarteg HCT |
Film coated tablet |
160 mg/ 25 mg |
mg |
28 |
EGIS Pharmaceuticals PLC, Унгария |
1 |
tabl |
- |
10.22 |
0.23964 |
6.71 |
50% |
3.36 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
№25/03.08.2009; НСР-843/07.08.2014и КП-16/05.03.2014 ; НСР-2824/21.02.2014 и КП-2/15.01.2015; НСР-6273/22.05.2015 (допуска предварително изпълнение) |
02.06.2015 |
08.09.2012 |
|
Заличен |
3498 |
| C09DA03 |
Valsartan, Hydrochlorothiazide |
SARTEG HCT |
Film coated tablet |
160 mg/25 mg |
mg |
30 |
EGIS Pharmaceuticals PLC, Унгария |
1 |
tabl |
- |
9.83 |
0.23964 |
7.19 |
50% |
3.59 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-6076/23.04.2015.; НСР-10093/18.08.2016; КП-10/15.02.2018 и НСР-14661/20.12.2017; НСР-18651/03.05.2019 |
02.06.2019 |
|
|
Заличен |
3843 |
| C09DA03 |
Valsartan, Hydrochlorothiazide |
SARTEG HCT |
Film coated tablet |
80 mg/12,5 mg |
mg |
30 |
EGIS Pharmaceuticals PLC, Унгария |
1 |
tabl |
- |
9.83 |
0.20925 |
6.28 |
50% |
3.14 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-6074/23.04.2015.; НСР-10091/18.08.2016; КП-11/15.02.2018 и НСР-14663/20.12.2017; НСР-18652/03.05.2019 |
02.06.2019 |
|
|
Заличен |
3841 |
| C09DA03 |
Valsartan, Hydrochlorothiazide |
SARTEG HCT |
Film coated tablet |
160 mg/12,5 mg |
mg |
30 |
EGIS Pharmaceuticals PLC, Унгария |
1 |
tabl |
- |
9.83 |
0.32767 |
9.83 |
50% |
4.91 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-6075/23.04.2015.; НСР-10092/18.08.2016; КП-12/15.02.2018 и НСР-14662/20.12.2017; НСР-18654/07.05.2019 |
02.06.2019 |
|
|
Заличен |
3842 |
| C09DA03 |
Valsartan, Hydrochlorothiazide |
Suvartar H |
Film coated tablet |
160 mg/12,5 mg |
mg |
28 |
Sandoz d.d., Словения |
1 |
tabl |
- |
11.12 |
0.32767 |
9.17 |
50% |
4.58 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
КЦРР-1704/27.11.2012 г.; НСР-5548/29.01.2015; НСР-9203/05.05.2016 |
02.06.2017 |
|
|
Активен |
3560 |
| C09DA03 |
Valsartan, Hydrochlorothiazide |
Suvartar H |
Film coated tablet |
160 mg/25 mg |
mg |
28 |
Sandoz d.d., Словения |
1 |
tabl |
- |
6.71 |
0.23964 |
6.71 |
50% |
3.36 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
КЦРР-1704/27.11.2012 г.; НСР-1326/03.10.2013; НСР-5159/27.11.2014 |
02.04.2016 |
|
|
Активен |
3408 |
| C09DA03 |
Valsartan, Hydrochlorothiazide |
Valsalen H |
Film coated tablet |
160 mg/12,5 mg |
mg |
28 |
Екофарм Груп АД, България |
1 |
tabl |
- |
17.92 |
0.32767 |
9.17 |
50% |
4.58 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
HCР-226/21.06.2013.; НСР-16791/20.09.2018 |
02.11.2018 |
|
|
Активен |
1968 |
| C09DA03 |
Valsartan, Hydrochlorothiazide |
Valsalen H |
Film coated tablet |
160 mg/25 mg |
mg |
28 |
Екофарм Груп АД, България |
1 |
tabl |
- |
13.42 |
0.23964 |
6.71 |
50% |
3.36 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
HCР-226/21.06.2013.; НСР-16792/20.09.2018 |
02.11.2018 |
|
|
Активен |
1969 |
| C09DA03 |
Valsartan, Hydrochlorothiazide |
Valsarcon-Co |
Film coated tablet |
160 mg/12,5 mg |
|
30 |
Фармаконс АД, България |
1 |
tabl |
- |
19.19 |
0.32767 |
9.83 |
50% |
4.91 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-11667/10.02.2017; НСР-15667/17.05.2018 |
02.06.2018 |
|
|
Активен |
15595 |
| C09DA03 |
Valsartan, Hydrochlorothiazide |
VALSAVIL COMP |
Film coated tablet |
160 mg/ 12,5 mg |
mg |
30 |
Stada Arzneimittel AG, Германия |
1 |
tabl |
- |
9.83 |
0.32767 |
9.83 |
50% |
4.91 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
№ 172/ 31.05.2011; НСР-2507/24.01.2014; НСР-12579/05.05.2017 |
02.06.2017 |
08.09.2012 |
|
Активен |
2475 |
| C09DA03 |
Valsartan, Hydrochlorothiazide |
VALSOL PLUS |
Film coated tablet |
160 mg/25 mg |
mg |
28 |
Инбиотех ООД, България |
1 |
tabl |
- |
7.45 |
0.23964 |
6.71 |
50% |
3.36 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
НСР-4559/03.09.2014 |
02.04.2016 |
|
|
Активен |
3161 |
| C09DA03 |
Valsartan, Hydrochlorothiazide |
Valtensin Plus |
Film coated tablet |
160 mg/25 mg |
mg |
28 |
Actavis Group PTC ehf., Исландия |
1 |
tabl |
- |
8.7 |
0.23964 |
6.71 |
50% |
3.36 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
№25/03.08.2009; КЦРР-2672/20.03.2013 г.; НСР-6684/09.07.2015.; КП-1/03.01.2018 и НСР-14175/13.10.2017 |
02.02.2018 |
08.09.2012 |
|
Активен |
1802 |
| C09DA03 |
Valsartan, Hydrochlorothiazide |
Valtensin Plus |
Film coated tablet |
320 mg/12,5 mg |
mg |
28 |
Actavis Group PTC ehf., Исландия |
1 |
tabl |
- |
17.17 |
0.58575 |
16.4 |
50% |
8.2 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
КЦРР-1104/02.08.2012 г.; НСР-3277/24.04.2014; НСР-13645/01.09.2017 |
02.10.2017 |
08.09.2012 |
|
Активен |
2752 |
| C09DA03 |
Valsartan, Hydrochlorothiazide |
Valtensin Plus |
Film coated tablet |
320 mg/25 mg |
mg |
28 |
Actavis Group PTC ehf., Исландия |
1 |
tabl |
- |
17.17 |
0.61321 |
17.17 |
50% |
8.58 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
КЦРР-958/16.07.2012 г.; НСР-3324/24.04.2014; НСР-13644/01.09.2017 |
02.10.2017 |
08.09.2012 |
|
Активен |
2751 |
| C09DA03 |
Valsartan, Hydrochlorothiazide |
Valtensin Plus |
Film coated tablet |
160 mg/ 12,5 mg |
|
28 |
Actavis Group PTC ehf., Исландия |
1 |
tabl |
- |
10.82 |
0.32767 |
9.17 |
50% |
4.58 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
№25/03.08.2009; КЦРР-2672/20.03.2013 г.; НСР-2517/24.01.2014; НСР-2804/17.02.2014 |
02.06.2017 |
08.09.2012 |
|
Активен |
2476 |
| C09DA03 |
Valsartan, Hydrochlorothiazide |
VALZAP H |
Film coated tablet |
160 mg/ 12,5 mg |
mg |
28 |
Zentiva k.s., Чешка република |
1 |
tabl |
- |
9.78 |
0.32767 |
9.17 |
50% |
4.58 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
№ 70/ 19.04.2010; № 119/10.11.2010; HCР-421/03.07.2013; НСР-7110/15.09.2015; НСР-10941/17.11.2016 |
02.06.2017 |
08.09.2012 |
|
Активен |
278 |
| C09DA03 |
Valsartan, Hydrochlorothiazide |
Vanatex HCT |
Film coated tablet |
160 mg/25 mg |
mg |
28 |
Pharmaceutical Works Polpharma S.A. (PL), Полша |
1 |
tabl |
- |
19.03 |
0.23964 |
6.71 |
50% |
3.36 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
КЦРР-1724/28.11.2012 г.; НСР-1084/02.09.2013; НСР-5464/16.01.2015; НСР-11171/08.12.2016 |
02.01.2017 |
|
|
Заличен |
3524 |
| C09DA03 |
Valsartan, Hydrochlorothiazide |
Vanatex HCT |
Film coated tablet |
160 mg/12,5 mg |
mg |
28 |
Pharmaceutical Works Polpharma S.A. (PL), Полша |
1 |
tabl |
- |
16.56 |
0.33475 |
9.37 |
50% |
4.69 |
|
I10,I11.0,I11.9,I12.0,I12.9,I13.0,I13.1,I13.2 |
КЦРР-1724/28.11.2012 г; НСР-1084/02.09.2013; НСР-5283/ 18.12.2014.; НСР-11171/08.12.2016 |
02.01.2017 |
|
|
Заличен |
3477 |